J-Pouch Coloanal Anastomosis Compared With Side-to-End Coloanal Anastomosis After Radiation Therapy and Surgery to Remove the Rectum in Treating Patients With Rectal Adenocarcinoma
A Phase III Randomised Study Of J-Pouch Coloanal Anastomosis Versus Side-To-End Coloanal Anastomosis After Preoperative Radiotherapy And Total Mesorectal Excision In Patients With Mid And Distal Rectal Cancer
3 other identifiers
interventional
100
1 country
9
Brief Summary
RATIONALE: A coloanal anastomosis may be effective in restoring bowel function after radiation therapy and surgery to remove the rectum. It is not yet known whether a J-pouch coloanal anastomosis is more effective than a side-to-end coloanal anastomosis in restoring bowel function in patients with rectal adenocarcinoma who have undergone radiation therapy and surgery to remove the rectum. PURPOSE: This randomized phase III trial is studying how well J-pouch coloanal anastomosis works compared to side-to-end coloanal anastomosis in treating patients with rectal adenocarcinoma who have undergone radiation therapy and surgery to remove the rectum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 colorectal-cancer
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2002
CompletedFirst Submitted
Initial submission to the registry
October 3, 2003
CompletedFirst Posted
Study publicly available on registry
October 7, 2003
CompletedAugust 7, 2013
April 1, 2007
October 3, 2003
August 6, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional outcome as measured by a validated questionnaire
Secondary Outcomes (2)
Quality life as measured by a validated questionnaire
Anorectal function as assessed by anorectal manometry and barostat measurements
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (9)
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Amsterdam, 1066 CX, Netherlands
St. Lucas - Andreas Ziekenhuis
Amsterdam, 1091 AE, Netherlands
Onze Lieve Vrouwe Gasthuis
Amsterdam, 1091 HA, Netherlands
Academisch Medisch Centrum at University of Amsterdam
Amsterdam, 1105 AZ, Netherlands
Gelre Ziekenhuizen - Lokatie Lukas
Apeldoorn, 7300 DS, Netherlands
Reinier de Graaf Group - Delft
Delft, 2625 AD, Netherlands
Albert Schweitzerziekenhuis - Locatie Amstelwijck
Dordrecht NM, NL-3317, Netherlands
Isala Klinieken - locatie Sophia
Zwolle, 8000 GK, Netherlands
Isala Klinieken - locatie Weezenlanden
Zwolle, 8000 GK, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Roel Bakx, MD
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE CARE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 3, 2003
First Posted
October 7, 2003
Study Start
June 1, 2002
Last Updated
August 7, 2013
Record last verified: 2007-04